Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee - Top-Institutions - MDSpire

Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee

  • By

  • Alessandro Criscimanna

  • Jacques-Emanuel Galimard

  • Isabel Sánchez-Ortega

  • Patrick J. Hayden

  • Laurent Garderet

  • Anna Sureda

  • Fabio Ciceri

  • Donal P. McLornan

  • Krzysztof Kałwak

  • Antonio M. Risitano

  • Francesco Onida

  • Ibrahim Yakoub-Agha

  • Ali Bazarbachi

  • Annalisa Ruggeri

  • June 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Brussels, Belgium

    Key Differentiators

    • Hematology
    • Transplantation

  • #2

    The University of North Carolina at Chapel Hill
    The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Northwestern University
    Northwestern University

    Chicago, Illinois

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee

  • by Alessandro Criscimanna, Jacques-Emanuel Galimard, Isabel Sánchez-Ortega, Patrick J. Hayden, Laurent Garderet, Anna Sureda, Fabio Ciceri, Donal P. McLornan, Krzysztof Kałwak, Antonio M. Risitano, Francesco Onida, Ibrahim Yakoub-Agha, Ali Bazarbachi, Annalisa Ruggeri

  • June 3, 2026

Related Content

A case report of splenic malignancy originating from the liver

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases